ALTHE — Theraclion SA Income Statement
0.000.00%
- €15.04m
- €12.16m
- €0.83m
Annual income statement for Theraclion SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | FAS | FAS | FAS | FAS | FAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.744 | 1.48 | 1.24 | 1.82 | 0.83 |
Cost of Revenue | |||||
Gross Profit | 0.453 | 1.02 | 0.769 | 1.49 | 0.356 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 5.04 | 5.99 | 7.19 | 4.59 | 7.62 |
Operating Profit | -4.3 | -4.51 | -5.96 | -2.77 | -6.79 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -4.63 | -4.64 | -5.97 | -4.72 | -6.74 |
Provision for Income Taxes | |||||
Net Income After Taxes | -3.91 | -3.76 | -4.96 | -3.67 | -5.76 |
Net Income Before Extraordinary Items | |||||
Net Income | -3.91 | -3.76 | -4.96 | -3.67 | -5.76 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -3.91 | -3.76 | -4.96 | -3.68 | -5.76 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.241 | -0.166 | -0.177 | -0.085 | -0.125 |
Dividends per Share |